Novavax Inc (NVAX)

EBITDA Growth

-135.62%

Quarterly · Period ending:

NVAX logo

NVAX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-135.62%
NVAX Quarterly EBITDA YoY % (0.00% → -135.62%)
High-resolution chart · PNG

NVAX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-135.617%
-100.1017%
153.9501%
-81.1919%
-32.9844%
513.7867%
66.9454%
10.143%
153.1257%
53.8128%
6.3097%
23.6498%
114.3225%
-228.3183%
78.9538%
49.9505%
-45.748%
202.2588%
-380.327%
-60.148%
-2,422.5359%
-872.5105%
-513.346%
-1,292.907%
61.0349%
42.7391%
36.6288%
64.8316%
11.2754%
6.4546%
2.7655%
-4.1749%
-0.3574%
-6.9056%
12.0351%
37.9432%
47.7224%
47.5353%
34.8774%
-92.1089%
-288.9226%
-216.4734%
-149.1852%
-69.0038%
-13.6129%
-71.9182%
-142.3018%
-28.0201%
-36.4646%
-40.8603%
-46.0765%
-112.6004%
-123.8795%
-35.2489%
-172.2459%
-72.6058%
6.9245%
0.4531%
25.991%
60.3121%
30.4884%
36.7091%
67.9631%
-25.5242%
-13.2412%
-63.0571%
-55.7541%
18.0556%
4.0316%
2.3962%
-169.9636%
-9.1277%
8.8499%
10.5626%
48.0863%
-65.2505%
-40.1858%
-95.0485%
-188.8469%
-326.7617%
-46.4311%
45.6157%
179.2327%
16.4683%
36.8366%
-73.9642%
-228.2023%
42.9219%
-52.4948%
17.0475%
40.4034%
58.2111%
16.9087%
1.1199%
-115.7698%
-318.9689%
-600.6693%
-278.3053%
55.4699%
53.7733%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.